Brief: Annexin Pharmaceuticals Q2 net loss at SEK 10.1 million
Aug 16 (Reuters) - ANNEXIN PHARMACEUTICALS AB (PUBL) ANNX.ST :
* Q2 NET LOSS SEK 10.1 MILLION VERSUS LOSS SEK 884,000 YEAR AGO
Source text for Eikon: ID:nWkr8mYcQg
Further company coverage: ANNX.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed